Home > PE Ratio > MERCURY LABORATORIES

MERCURY LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of MERCURY LABORATORIES is 25.56.

Share Price ₹875.8Apr 25,2024
Market Cap ₹105.1 Cr
Earnings-TTM₹4.1 CrTTM-Standalone Results
Price/Earnings25.56xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MERCURY LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of MERCURY LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MERCURY LABORATORIES is calculated as :

Current Market Cap [ ₹105.1 Cr] as on Apr 25,2024

(/) Earnings [ ₹4.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 25.56x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MERCURY LABORATORIES , the investors are currently willing to pay 25.56 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MERCURY LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MERCURY LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of MERCURY LABORATORIES


PE Ratio Performance Analysis for MERCURY LABORATORIES

- MERCURY LABORATORIES 's latest p/e ratio is 25.56x.

- MERCURY LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 13.63x.

- MERCURY LABORATORIES 's operated at median p/e ratio of 14.34x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MERCURY LABORATORIES 's p/e ratio peaked in Mar2022 at 16.34x.

- MERCURY LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 10.45x.


How does MERCURY LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MERCURY LABORATORIES 4.1125.56105.1
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.54364,831.0
CIPLA LTD3,744.0330.31113,471.0
DR REDDYS LABORATORIES LTD5,209.4019.91103,713.0
ZYDUS LIFESCIENCES LTD2,954.2032.3995,687.8
DIVIS LABORATORIES LTD1,382.9773.73101,960.0
MANKIND PHARMA LTD1,743.3055.1296,093.1
TORRENT PHARMACEUTICALS LTD1,494.0060.9991,124.7
LUPIN LTD1,809.7440.1672,687.6
AUROBINDO PHARMA LTD2,777.8923.2864,661.3
ABBOTT INDIA LTD1,145.5847.6054,533.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MERCURY LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.91x
Max industry PE 73.73x
Median industry PE 40.16x
Average industry PE 40.87x



You may also like the below Video Courses